Pages that link to "Q48736826"

The following pages link to In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution (Q48736826):

Displaying 38 items.

• Pharmacokinetic Determinants of Drug Abuse and Dependence (Q22305838) (← links)
• Benzodiazepine Poisoning Clinical and Pharmacological Considerations and Treatment (Q22305844) (← links)
• Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerations (Q33770253) (← links)
• Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration (Q34054840) (← links)
• Rate of binding of various inhibitors at the dopamine transporter in vivo (Q34288926) (← links)
• Obesity effects on nitrazepam disposition (Q34448167) (← links)
• Pharmacokinetic and Pharmacodynamic Principles of Illicit Drug Use and Treatment of Illicit Drug Users (Q34448544) (← links)
• Clinical considerations in transitioning patients with epilepsy from clonazepam to clobazam: a case series. (Q34996385) (← links)
• Serum concentration and drug effect after intravenous and rectal administration of diazepam (Q36345030) (← links)
• Adult sedation: oral, rectal, IM, IV (Q37058695) (← links)
• Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study (Q37343658) (← links)
• Clinical pharmacokinetics of non-opiate abused drugs (Q38344189) (← links)
• Midazolam: review of a versatile agent for use in dentistry (Q39683217) (← links)
• Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation (Q40511664) (← links)
• Midazolam exhibits characteristics of a highly permeable P-glycoprotein substrate. (Q40647286) (← links)
• The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma (Q41768929) (← links)
• Recovery following sedation with midazolam or diazepam alone or in combination with fentanyl for outpatient surgery (Q41774121) (← links)
• Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration (Q41775186) (← links)
• Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship (Q41827086) (← links)
• A comparison of transcutaneous PO2 in patients sedated with diazepam-fentanyl or midazolam-fentanyl (Q41853354) (← links)
• Ionization states, cellular toxicity and molecular modeling studies of midazolam complexed with trimethyl-β-cyclodextrin. (Q42689617) (← links)
• In vivo cerebral pharmacokinetics and pharmacodynamics of diazepam and midazolam after short intravenous infusion administration in sheep (Q43623388) (← links)
• A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures (Q43689011) (← links)
• Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam, and oxazepam (Q43783814) (← links)
• Benzodiazepine pharmacodynamics: evidence for biophase rate limiting mechanisms. (Q46024717) (← links)
• Pharmacokinetic modeling of the anticonvulsant response of oxazepam in rats using the pentylenetetrazol threshold concentration as pharmacodynamic measure (Q48089225) (← links)
• Kinetics, brain uptake, and receptor binding characteristics of flurazepam and its metabolites (Q48166050) (← links)
• Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity (Q48256985) (← links)
• Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam (Q48583932) (← links)
• Distribution of diazepam, nordiazepam, and oxazepam between brain extraneuronal space, brain tissue, plasma, and cerebrospinal fluid in diazepam and nordiazepam dependent dogs (Q48805735) (← links)
• Relationship between drug plasma concentrations and psychomotor performance after single doses of ethanol and benzodiazepines (Q48891327) (← links)
• Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. II. Triazolam (Q50798257) (← links)
• Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam (Q50798434) (← links)
• Development of acute tolerance after oral doses of diazepam and flunitrazepam (Q51646898) (← links)
• Differences in diazepam pharmacokinetics in Chinese and white Caucasians--relation to body lipid stores (Q51798441) (← links)
• Relationship between receptor occupancy at 37 degrees C and the anticonvulsant effect of flunitrazepam in rats (Q69357607) (← links)
• Stability and pharmacokinetics of flumazenil in the rat (Q70201988) (← links)
• A comparison of the acute behavioral effects of flunitrazepam and triazolam in healthy volunteers (Q71304562) (← links)